JW Lifescience Corporation (234080.KS) KSC

13,300.00

-130(-0.97%)

Updated at October 24 03:30PM

Currency In KRW

Valuation

Market Cap168.48B
Enterprise Value230.2B
P/E Ratio4.17
PEG Ratio0.42
Price/Sales Ratio0.85
Price/Book Ratio0.98
Enterprise/Revenue1.04
Enterprise/EBITDA2.97

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.2
Operating Margin0.15

Management Effectiveness

Return On Assets0.16
Return On Equity0.25

Income Statement

Revenue222.48B
Revenue/Share15,717.56
Gross Profit57.51B
EBITDA76.82B
Net Income43.99B
Diluted EPS2,842.77

Balance Sheet

Total Cash27.29B
Total Cash/Share1,760.6
Total Debt56.54B
Total Debt/Equity0.27
Current Ratio1.13
Book Value Per Share13,546.85

Price History

52-Week Change21.24
52-Week High13,600
52-Week Low10,000
Moving Average 50 Days12,146.6
Moving Average 200 Days11,658.3

Statistics

Average Volume40,127
Shares Outstanding15.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate500
Trailing Annual Dividend Yield3.76
Payout Ratio0.16
Last Split Factor2:1
Last Split DateMay 15, 2018